The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...

While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...

We do not offer financial advice, advisory or brokerage services, nor do we recommend or advise individuals or to buy or sell particular stocks or securities. Performance information may have ...